Is a complete EDSA research report available?

No complete published report is available for Edesa Biotech, Inc. (EDSA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Edesa Biotech, Inc. (EDSA)

NASDAQ: EDSA · USD

$5.25

-0.11 (-2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first EDSA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	46.7M
Net income (ttm)	-10.4M
EPS (ttm)	-$1.37
Shares out	8.9M
Volume	76,296
Beta	1.05
Price target	$16.3	+211.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -10.4M
EPS (ttm): -$1.37
Market cap: 46.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All EDSA indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001540159
Company name	Edesa Biotech, Inc.
Country	Canada
Country code	US
Cusip	27966L306
Employees	17
Employees Change	1%
Employees Change Percent	6.25
Enterprise value	$35.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA27966L3065
Last refreshed	2026-07-31
Market cap	$46.7M
Market cap category	Nano-Cap
Price	$5.25
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	EDSA
Website	https://www.edesabiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.12%
FCF yield	-16.66%
P/B ratio	26.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-9,069.26%
EBITDA Margin	-8,973.73%
Net Income	$-10.4M
Net Income Growth Years	0%
Profit Per Employee	$-614,343
ROA	-47.73
Roa5y	-77.39
ROCE	-95.88
ROE	-81.16
Roe5y	-123
ROIC	-53.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	129.39%
Cagr3y	-1.69%
Cagr5y	-31.38%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$12.4M
Cash	$10M
Current Assets	$10.4M
Current Liabilities	$2.2M
Debt	$0
Equity	$10.2M
Liabilities	$2.2M
Long Term Assets	$2M
Long Term Liabilities	$0
Net Cash	$10M
Net Cash By Market Cap	$22.15
Net Cash Growth	-28.01%
Net Debt Equity	$-0.98
Tangible Book Value	$-105,056
Tangible Book Value Per Share	$-0.01
WACC	10.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.76
Net Working Capital	$-1.8M
Quick ratio	4.67
Working Capital	$8.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-102.57%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	129.26%
200-day SMA	4.9
3Y total return	-4.99%
50-day SMA	7.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-84.79%
All Time High	133.7
All Time High Change	-96.07%
All Time High Date	2020-07-30
All Time Low	0.72
All Time Low Change	629.17%
All Time Low Date	2026-02-20
ATR	0.71
Beta	1.05
Beta1y	-2.61
Beta2y	-0.41
Ch YTD	269.7
High	5.5
High52	20.32
High52 Date	2026-05-01
High52ch	-74.16%
Low	4.92
Low52	0.72
Low52 Date	2026-02-20
Low52ch	629.17%
Ma50ch	-25.29%
Premarket Change Percent	-4.66
Premarket Price	$5.11
Price vs 200-day SMA	7.12%
RSI	36.08
RSI Monthly	49.67
RSI Weekly	47.17
Sharpe ratio	1.17x
Sortino ratio	2.93
Total Return	-102.57%
Tr YTD	269.7
Tr1m	-31.55%
Tr1w	-7.24%
Tr3m	-66.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.44
Operating Income	$-11M
Price target	$16.33
Price Target Change	$211

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,858,973%
Float Percent	54.64%
Shares Insiders	15.17%
Shares Institutions	19.9%
Shares Out	8,891,951
Shares Qo Q	7.13%
Shares Yo Y	102.57%
Short Float	5.82%
Short Ratio	2.65
Short Shares	3.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9M
Adjusted OCF	-8,992,238
Average Volume	65,101.15x
Bv Per Share	0.21
Ch1m	-31.55
Ch1w	-7.24
Ch1y	129.3
Ch3m	-66.98
Ch3y	-4.99
Ch5y	-84.79
Ch6m	326.8
Change	-2.05%
Change From Open	-0.76
Close	5.36
Days Gap	-1.31
Depreciation Amortization	102,987
Dollar Volume	400,554
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-9.8M
EBITDA	$-9.7M
EPS	$-1.37
F Score	1
FCF	$-7.5M
FCF EV Yield	-21.4x
FCF Per Share	$-0.85
Financing CF	3,532,922
Fiscal Year End	September
Founded	2,015
Income Tax	$800
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2023-10-11
Last Split Type	Reverse
Last10k Filing Date	2025-12-12
Ma150	5.9
Ma150ch	-10.99%
Ma20	6.32
Ma20ch	-16.97%
Net CF	-3,892,967
Next Earnings Date	2026-08-11
Open	5.29
Optionable	No
Position In Range	56.9
Pre Close	5.36
Price Date	2026-07-30
Relative Volume	1.17x
Share Based Comp	1,466,521
Tr6m	326.83%
Volume	76,296

Edesa Biotech, Inc. (EDSA)

Coverage state: Market snapshot only — no published research

Generate the first EDSA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · EDSA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EDSA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EDSA

Frequently asked questions